Neuren Pharmaceuticals | NEU - Ebitda





Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -5.56M 4.13M 2026-06
Clinuvel Pharmaceuticals AUD 27.55M 12.65M 2025-06
Dianthus Therapeutics USD -61.38M 14.92M 2026-06
Genetic Signatures AUD -7.11M 970K 2024-12
Ionis Pharmaceuticals USD -85.24M 20.71M 2026-06
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organon & Co USD 502M 131M 2026-09
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Starpharma Holdings AUD -4.85M 1.73M 2024-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Telix Pharmaceuticals AUD 76.49M 58.07M 2026-06
Viatris USD 1.2B 7.4M 2026-09
Xeris Pharmaceuticals USD -20.94M 33.27M 2026-06